CN1060086C - Traditional Chinese medicine capsule for eliminating indurated goiter - Google Patents

Traditional Chinese medicine capsule for eliminating indurated goiter Download PDF

Info

Publication number
CN1060086C
CN1060086C CN98107184A CN98107184A CN1060086C CN 1060086 C CN1060086 C CN 1060086C CN 98107184 A CN98107184 A CN 98107184A CN 98107184 A CN98107184 A CN 98107184A CN 1060086 C CN1060086 C CN 1060086C
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
aspongopus
eliminating
shallow oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98107184A
Other languages
Chinese (zh)
Other versions
CN1194158A (en
Inventor
苏恩平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98107184A priority Critical patent/CN1060086C/en
Publication of CN1194158A publication Critical patent/CN1194158A/en
Application granted granted Critical
Publication of CN1060086C publication Critical patent/CN1060086C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention belongs to the field of traditional Chinese medicine preparation product. The traditional Chinese medicine capsule comprises components with the proportion by weight: 8.5 to 9.5% of aspongopus, 8.5 to 9.5% of mume flower, 7 to 8% of earthworm, 7 to 8% of tokay gecko, 14 to 16% of pangolin scale, 10.5 to 11.8% of turtle shell, 4 to 5% of tamariskoid spikemoss herb, 4 to 5% of prepared olibanum, 4 to 5% of prepared myrrh, 10.5 to 11.8% of szechwan chinaberry fruit, 8 to 10% of rhizoma corydalis and 7 to 8% of ground beeltle. The medicines are made into granules and encapsulated after being infused and dried. The traditional Chinese medicine capsule has the efficiency of activating blood circulation to dissipate blood stasis, softening and resolving hard mass, eliminating stones and relieving pain, and has obvious therapeutic effect on diseases of cholecystitis, gallstone, urinary calculus, thyroid enlargement, prostatomegaly, prostatitis, etc.

Description

The eliminating indurated goiter Chinese medicinal capsule
The invention belongs to the Chinese medicine product field.
Existing treatment cholelithiasis Chinese patent medicine kind is a lot, but in use effect is not ideal mostly, and some medicine commonly used such as the intestines and stomach have stimulation, and pharmaceutical compositions has harmful effect to heart disease, myasthenia gravis etc., and side effect is bigger.Patent Office of the People's Republic of China's on August 27th, 97, disclosed " liver and gall litholytic capsule " (publication number CN1157726A) introduced a kind of treatment liver and bile stone medicine; prescription is: Herba clerodendranthi spicati, Endothelium corneum Anas domestica, Spora Lygodii, yellow young powder, Squama Manis, succinum, Rhizoma Curcumae Longae, Radix Et Rhizoma Rhei, Radix Curcumae, Calculus Bovis, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae etc.; has depressed liver-energy dispersing and function of gallbladder promoting; removing damp-heat, the effect of softening the hard mass calculi dissolving.But it is comparatively single that this medication is imitated, effective to cholelithiasis, and urinary system calculus and prostatauxe, thyromegaly are not almost had effect.
The objective of the invention is weak point not satisfactory at the curative effect of medication of existing treatment calculus or that therapeutic domain is narrow, a kind of treatment plurality of calculi disease and thyroid, prostatitis are provided, the significant Chinese medicinal capsule of therapeutic effect.
Technical scheme of the present invention is such: each raw material weight ratio of this Chinese medicinal capsule is: Aspongopus 8.5-9.5%, FLOS MUME 8.5-9.5%, Pheretima 7-8%, Gecko 7-8%, Squama Manis 14-16%, Carapax Trionycis 10.5-11.8%, Herba Selaginellae 4-5%, Olibanum (processed) 4-5%, Myrrha (processed) 4-5%, Fructus Toosendan 10.5-11.8%, Rhizoma Corydalis 8-10%, Eupolyphaga Seu Steleophaga 7-8%; Aspongopus, FLOS MUME, Pheretima, Gecko, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis are ground into fine powder cross 200 mesh sieves, Squama Manis, Carapax Trionycis, Herba Selaginellae, Olibanum, Myrrha, Fructus Toosendan were soaked in water 3 days, fry in shallow oil then three times, fried in shallow oil 1 hour at every turn, the medicinal liquid of frying in shallow oil for three times is mixed, decocting and concentrating becomes thick paste, the Six-element medicated powder of ointment and front is mixed, stir, make granule after the oven dry, incapsulate.
The present invention has following advantage:
1. this Chinese medicinal capsule has the effect of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, Sal Nitri analgesic therapy, and diseases such as cholecystitis, cholelithiasis, urinary system calculus, thyromegaly, prostate hyperplasia, prostatitis are all had significant curative effect.
2. the prescription of this Chinese medicinal capsule is formed all medicine uniquenesses, the side's of system principle is to set out with integral body, and from pathogenic mechanism, medicines such as conventional 'Shugan Lidan ' medicine, inducing diuresis for treating stranguria syndrome are almost useless, therapeutic effect gets instant result, and can reach the clinical cure purpose 2-3 courses of treatment of taking medicine.
Embodiments of the invention are as follows:
This medicine composition each component weight ratio is: Aspongopus 8.5-9.5%, FLOS MUME 8.5-9.5%, Pheretima 7-8%, Gecko 7-8%, Squama Manis 14-16%, Carapax Trionycis 10.5-11.8%, Herba Selaginellae 4-5%, Olibanum (processed) 4-5%, Myrrha (processed) 4-5%, Fructus Toosendan 10.5-11.8%, Rhizoma Corydalis 8-10%, Eupolyphaga Seu Steleophaga 7-8%; Aspongopus, FLOS MUME, Pheretima, Gecko, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis are ground into fine powder cross 200 mesh sieves, Squama Manis, Carapax Trionycis, Herba Selaginellae, Olibanum, Myrrha, Fructus Toosendan were soaked in water 3 days, fry in shallow oil then three times, fried in shallow oil 1 hour at every turn, the medicinal liquid of frying in shallow oil for three times is mixed, decocting and concentrating becomes thick paste, the Six-element medicated powder of ointment and front is mixed, stir, make granule after the oven dry, incapsulate.Each capsule explosive payload is 0.2g.
When taking every day secondary, each 2, one month is a course of treatment.

Claims (1)

1. the eliminating indurated goiter Chinese medicinal capsule is characterized in that each raw material weight ratio of this Chinese medicinal capsule is: Aspongopus 8.5-9.5%, FLOS MUME 8.5-9.5%, Pheretima 7-8%, Gecko 7-8%, Squama Manis 14-16%, Carapax Trionycis 10.5-11.8%, Herba Selaginellae 4-5%, Olibanum (processed) 4-5%, Myrrha (processed) 4-5%, Fructus Toosendan 10.5-11.8%, Rhizoma Corydalis 8-10%, Eupolyphaga Seu Steleophaga 7-8%; Aspongopus, FLOS MUME, Pheretima, Gecko, Eupolyphaga Seu Steleophaga, Rhizoma Corydalis are ground into fine powder cross 200 mesh sieves, Squama Manis, Carapax Trionycis, Herba Selaginellae, Olibanum, Myrrha, Fructus Toosendan were soaked in water 3 days, fry in shallow oil then three times, fried in shallow oil 1 hour at every turn, the medicinal liquid of frying in shallow oil for three times is mixed, decocting and concentrating becomes thick paste, the Six-element medicated powder of ointment and front is mixed, stir, make granule after the oven dry, incapsulate.
CN98107184A 1998-04-11 1998-04-11 Traditional Chinese medicine capsule for eliminating indurated goiter Expired - Fee Related CN1060086C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98107184A CN1060086C (en) 1998-04-11 1998-04-11 Traditional Chinese medicine capsule for eliminating indurated goiter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98107184A CN1060086C (en) 1998-04-11 1998-04-11 Traditional Chinese medicine capsule for eliminating indurated goiter

Publications (2)

Publication Number Publication Date
CN1194158A CN1194158A (en) 1998-09-30
CN1060086C true CN1060086C (en) 2001-01-03

Family

ID=5219259

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98107184A Expired - Fee Related CN1060086C (en) 1998-04-11 1998-04-11 Traditional Chinese medicine capsule for eliminating indurated goiter

Country Status (1)

Country Link
CN (1) CN1060086C (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030641A (en) * 1987-07-10 1989-01-25 浙江大学 The Mei Er moire fringe testing method and the device thereof of minute surface flatness

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030641A (en) * 1987-07-10 1989-01-25 浙江大学 The Mei Er moire fringe testing method and the device thereof of minute surface flatness

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《广西中医药》1993年第16卷第4期 1993.1.1 李士桂,公核饮 *
《广西中医药》1993年第16卷第4期 1993.1.1 李士桂,公核饮;《湖南中医杂志》1986年第2卷第3期 1986.1.1 王敬璇,以化石丸为主治疗泌尿系统结石100例临床观察 *
《湖南中医杂志》1986年第2卷第3期 1986.1.1 王敬璇,以化石丸为主治疗泌尿系统结石100例临床观察 *

Also Published As

Publication number Publication date
CN1194158A (en) 1998-09-30

Similar Documents

Publication Publication Date Title
CN101066303B (en) Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation
CN1101692C (en) Method for preparing Chinese medicine for curing apoplexy and hemiparalysis
CN100998838A (en) Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof
CN100381146C (en) Traditional Chinese medicine for treating rheumatism
CN101327305A (en) Chinese medicine for treating appendicitis and preparation method thereof
CN110755517A (en) Pain-relieving liquid
CN1059105C (en) Bi Syndrome curing medicine
CN1071123C (en) Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites
CN1060086C (en) Traditional Chinese medicine capsule for eliminating indurated goiter
CN108186749A (en) Treat Chinese medicine composition of cervical spondylosis and preparation method thereof
CN1283302C (en) Medicament for treating rheumatoid arthritis and artjritis pauperum
CN1133458C (en) Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk
CN1129439C (en) Hyperosteogeny-treating capsule
CN101284087B (en) Medicinal composition for curing lumbar disease
CN102000286A (en) Traditional Chinese medicine preparation for treating polyneuritis
CN101987128A (en) Traditional Chinese medical preparation for treating urticaria
CN100358552C (en) Medicine for treating amblyopia and its preparing method
CN100402077C (en) Medicinal composition for treating hyperosteogency
CN1055006C (en) Chinese medicine for curing thrombus, rheumatism and other diseases
CN1175875C (en) Medicine made of lysimachia for treating hepatobiliary calculus and its prescription
CN115192689B (en) Traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain, application and traditional Chinese medicine preparation thereof
CN1163256C (en) Chinese herb medicine composition for curing chronic colitis, gastritis and gastric ulcer radically
CN102028886A (en) Chinese medicinal preparation for treating tetanus
CN102178883B (en) Preparation method of traditional Chinese medicine for treating hunger type frostbite
CN1225269C (en) Medicine for treating prospoalgia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20010103

Termination date: 20130411